Home2025-06-06T16:27:10+02:00

Unleash the full potential of mRNA with the All-ScaleFlow™ technology

We are developing cutting-edge equipment to enhance global healthcare access by simplifying and improving the production of mRNA vaccines and therapies.

A REVOLUTIONARY APPROACH WITH A GAME-CHANGING TECHNOLOGY

All-ScaleFlow™-based-equipment allows to produce mRNA vaccines and therapeutics faster, all over the world, at any scale!

0

Doses
Minimum scale

0M

Doses
Annual capacity

0m²

Only
Equipment footprint

Industry professionals encounter many challenges in producing mRNA-based-therapeutics.

The COVID-19 pandemic revealed the limits of multi-step batch production for vaccines, highlighting the need for new approaches. The future now belongs to continuous & automated mRNA manufacturing processes.

Industry professionals encounter many challenges in producing mRNA-based-therapeutics.

The COVID-19 pandemic revealed the limits of multi-step batch production for vaccines, highlighting the need for new approaches. The future now belongs to continuous & automated mRNA manufacturing processes.

FROM EARLY DEVELOPMENT TO COMMERCIAL MANUFACTURING

All-ScaleFlow™-based-equipment removes major industrial roadblocks in the production of mRNA-LNP

FROM EARLY DEVELOPMENT TO COMMERCIAL MANUFACTURING

All-ScaleFlow™-based-equipment

removes major industrial roadblocks in the production of mRNA-LNP

PARTNERS

They trust us

NEWS

Dillico moved

We are thrilled to announce that we are transitioning our site to a new location. As of now, we'll be located at Inovallée, Meylan; near our previous office in Grenoble. We’re heading to [...]

18 October 2023|
Read More

Dillico Grand Prix i-Lab 2023

Dillico Grand Prix i-Lab 2023 (English version below) Nous sommes honorés d'avoir été choisis parmi de nombreux candidats exceptionnels, comme lauréat du Grand prix i-Lab 2023 ! Ce prix revêt une importance particulière car [...]

6 July 2023|
Read More

Headquarters